Abbott Labs

Wall Street's consensus sees the S&P 500 tacking on an 11% gain over the next 12 months -- with lots of ups and downs along the way. That has us inclined to play defense, with an eye toward bargain stocks paying generous, sustainable dividends. Here are our top 11 picks for 2011.

Abbott Laboratories is recalling roughly 359 million blood-sugar test strips for diabetics after the strips turned out to yield falsely low readings.

If you've experienced sticker shock at the pharmacy and wondered why drug prices are always rising, even for generics, consider the value of salt. Baxter International, which sells drugs to health care providers and pharmacies, billed Medicaid $928 for $1.71 worth of saline solution -- a 54,000%...

Abbott Laboratories agreed to withdraw diet drug Meridia, after clinical trial data concluded that the drug increased the risk of heart attack and stroke and did little to help people lose weight. The Food and Drug Administration announced the recall of Meridia, which has become a highly-popular...

Abbott has recalled 5 million containers of its top-selling powdered baby formula, Similac, after finding beetles at one of its factories. But parents shouldn't panic, the company says. The chances that any beetlejuice actually made it into the formula is slim, and doctors say babies wouldn't be harmed even if it did.

Abbott Laboratories is recalling 5 million containers of its best-selling Similac infant formula over concerns that the powdered formulas are contaminated by insect parts or larvae, the company said. Abbott said a beetle was found in the production area of a manufacturing facility and says it...

The New England Journal of Medicine called Meridia "another flawed diet pill" -- two weeks before government advisers are scheduled to review the drug -- after a study finds it raises the risk of heart attack and stroke in users with heart problems.

The case of Abbott Laboratories' (ABT) cholesterol drug TriCor is quite interesting. The drug has been a blockbuster, and it has been under patent protection for decades. That's right, decades. Now, Abbott has managed to seal a deal with generic-drug maker Teva Pharmaceuticals Industries (TEVA)...